Biotechnology Archives -

Genotyping Market was valued at US$ 30.44 Billion in 2023 and is expected to reach US$ 154.35 Billion by 2031; it is estimated to record a CAGR of 22.5% from 2023 to 2031

Market News Insights May 8, 2025

Use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in...

North America In-Vitro Diagnostics Market was valued at US$ 56,890.44 Million in 2022 and is expected to reach US$ 78,479.05 Million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

North America In-Vitro Diagnostics Market was valued at US$ 56,890.44 Million in 2022 and is expected to reach US$ 78,479.05 Million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

Market News Insights April 28, 2025

North America is at the forefront of personalized medicine and genomics research. There is increasing integration of...

North America Point-of-Care Molecular Testing for Infectious Diseases Market was valued at US$ 1.09 Billion in 2023 and is expected to reach US$ 2.62 Billion by 2031; it is estimated to record a CAGR of 11.5% from 2023 to 2031

North America Point-of-Care Molecular Testing for Infectious Diseases Market was valued at US$ 1.09 Billion in 2023 and is expected to reach US$ 2.62 Billion by 2031; it is estimated to record a CAGR of 11.5% from 2023 to 2031

Market News Insights April 25, 2025

Surging Prevalence of Infectious Diseases Drives North America Point-of-Care Molecular Testing for Infectious Diseases Market Infectious diseases...

US and Europe Cell and Gene Therapy Manufacturing Services Market was valued at US$ 4,773.5 Million in 2022 and is expected to reach US$ 16,869.1 Million by 2030; it is estimated to record a CAGR of 17.1% from 2022 to 2030

US and Europe Cell and Gene Therapy Manufacturing Services Market was valued at US$ 4,773.5 Million in 2022 and is expected to reach US$ 16,869.1 Million by 2030; it is estimated to record a CAGR of 17.1% from 2022 to 2030

Market News Insights April 23, 2025

Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and...

US and Europe Gene Editing Market was valued at US$ 3,955.09 Million in 2022 and is expected to reach US$ 15,052.92 Million by 2030; it is estimated to record a CAGR of 18.2% from 2023 to 2030

Market News Insights April 23, 2025

Flourishing Biotechnology Industry in US and Europe to Offer Opportunities for US and Europe Gene Editing Market...

Organ Preservation Solution Market was valued at US$ 274.41 Million in 2023 and is expected to reach US$ 512.62 Million by 2031; it is estimated to record a CAGR of 8.2% from 2023 to 2031

Market News Insights April 16, 2025

Strategic Initiatives by Market Players Expected to Provide Opportunities to Organ Preservation Solution Market Various market players...

Anatomic Pathology Market was valued at US$ 30.22 Billion in 2023 and is expected to reach US$ 53.27 Billion by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031

Market News Insights April 14, 2025

The increase in the prevalence of cancer and kidney diseases and the rise in the number of...

Organoids Services Market was valued at US$ 3.03 Billion in 2023 and is expected to reach US$ 15.01 Billion by 2031; it is estimated to record a CAGR of 22.3% from 2023 to 2031

Market News Insights April 14, 2025

Organoids are developed from stem cells, which are unbounded multiplicity cells that give rise to a variety...

Mononucleosis Diagnostic Market was valued at US$ 151.44 Million in 2023 and is expected to reach US$ 222.15 Million by 2031; it is estimated to record a CAGR of 4.9% from 2023 to 2031

Market News Insights April 10, 2025

Mononucleosis Diagnostic Market Analysis High risk among the adolescent population, and the rising health awareness and knowledge...

Latin America Chemiluminescence Immunoassay Market was valued at US$ 497.67 Million in 2023 and is expected to reach US$ 955.12 Million by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

Latin America Chemiluminescence Immunoassay Market was valued at US$ 497.67 Million in 2023 and is expected to reach US$ 955.12 Million by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

Market News Insights April 2, 2025

Chemiluminescence immunoassays (CLIA) can detect substances that cannot be identified in radioimmunoassays (RIA) and enzyme-linked immunosorbent assays...

Biotechnology

Genotyping Market was valued at US$ 30.44 Billion in 2023 and is expected to reach US$ 154.35 Billion by 2031; it is estimated to record a CAGR of 22.5% from 2023 to 2031

North America In-Vitro Diagnostics Market was valued at US$ 56,890.44 Million in 2022 and is expected to reach US$ 78,479.05 Million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

North America Point-of-Care Molecular Testing for Infectious Diseases Market was valued at US$ 1.09 Billion in 2023 and is expected to reach US$ 2.62 Billion by 2031; it is estimated to record a CAGR of 11.5% from 2023 to 2031

US and Europe Cell and Gene Therapy Manufacturing Services Market was valued at US$ 4,773.5 Million in 2022 and is expected to reach US$ 16,869.1 Million by 2030; it is estimated to record a CAGR of 17.1% from 2022 to 2030

US and Europe Gene Editing Market was valued at US$ 3,955.09 Million in 2022 and is expected to reach US$ 15,052.92 Million by 2030; it is estimated to record a CAGR of 18.2% from 2023 to 2030

Organoids Services Market was valued at US$ 3.03 Billion in 2023 and is expected to reach US$ 15.01 Billion by 2031; it is estimated to record a CAGR of 22.3% from 2023 to 2031

Mononucleosis Diagnostic Market was valued at US$ 151.44 Million in 2023 and is expected to reach US$ 222.15 Million by 2031; it is estimated to record a CAGR of 4.9% from 2023 to 2031

Latin America Chemiluminescence Immunoassay Market was valued at US$ 497.67 Million in 2023 and is expected to reach US$ 955.12 Million by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

You may have missed

US Healthcare Insurance Third-Party Administrator Market was valued at US$ 64.92 Billion in 2024 and is expected to reach US$ 144.86 Billion by 2031; it is estimated to record a CAGR of 12.1% from 2024 to 2031

Energy Management System Market Market was valued at US$ 49.5 Billion in 2024 and is expected to reach US$ 105.2 Billion by 2031; it is estimated to record a CAGR of 11.4% from 2024 to 2031

Remote Access Solution Market was valued at US$ 2.60 Billion in 2024 and is expected to reach US$ 8.65 Billion by 2031; it is estimated to record a CAGR of 19.4% from 2024 to 2031

Military Vehicle Market was valued at US$ 32.47 Billion in 2024 and is expected to reach US$ 65.53 Billion by 2031; it is estimated to record a CAGR of 10.8% from 2025 to 2031